Dipexium and PLx Pharma Announce Merger Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- Wall St falls as Trump's Iran remarks rattle investors; Broadcom gains
- Oil prices jump 7% as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- GameStop stockholders approve share count increase to 2.5 billion
Dipexium Pharma (DPRX) Doubles Following Merger Deal with PLx Pharma
December 22, 2016 5:20 PM ESTDipexium Pharma (NASDAQ: DPRX) resumed trading and is up 97% after announced today that they have entered into a definitive agreement under which PLx Pharma will merge with a wholly-owned subsidiary of Dipexium in an all-stock transaction. Following closing, Dipexium will be renamed... More
Dipexium Pharma (DPRX) to Resume Trading at 5:10 PM ET
December 22, 2016 4:47 PM ESTDipexium Pharma (NASDAQ: DPRX) to Resume Trading at 5:10 PM ET
... More